YONEHIRO GRANT (Chief Business Officer) sold 43.3% of their position (13.18K shares) of BOLT BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $43.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/21/2026ACC: 0001193125-26-396894
Officer· Chief Business Officer
Since Feb 2021
-13.18K
Net shares
Net seller
$43.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
13.18K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.42K
Price / share
$3.77
Trade value
$5.35K
% of position
4.7%
9/16/2026
30.45K→29.03K
Common Stock
Direct
Shares
−4.91K
Price / share
$3.32
Trade value
$16.29K
% of position
16.9%
9/17/2026
29.03K→24.12K
Common Stock
Direct
Shares
−6.85K
Price / share
$3.24
Trade value
$22.17K
% of position
28.4%
9/18/2026
24.12K→17.27K
Total
Net shares
−13.18K
Net value
-$43.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2026 | S · Sale | −1.42K | $3.77 | $5.35K | 4.7% | 30.45K | 29.03K |
| Common Stock Direct | 9/17/2026 | S · Sale | −4.91K | $3.32 | $16.29K | 16.9% | 29.03K | 24.12K |
| Common Stock Direct | 9/18/2026 | S · Sale | −6.85K | $3.24 | $22.17K | 28.4% | 24.12K | 17.27K |
| Total | −13.18K | -$43.81K | ||||||
Derivative Transactions0
No derivative transactions reported